Results 71 to 80 of about 18,349 (180)

A Case of Serious Adverse Reaction Following Rabies Vaccination

Global Pediatric Health, 2018
Introduction . Rabies is one of the most deadly infectious disease. We present a challenging case of an adverse reaction following rabies vaccine in a child. Case Summary .
Zhilin Kang MBBS, MRCPCH, MMED (Paediatrics), Wen Chin Chiang BMedSci, MBBS, MRCPCH, FAMS, Si Hui Goh MBBS, MRCPCH, MMED (Paediatrics), Anne Eng Neo Goh MBBS, MMED (Paediatrics), FRCPCH, FAMS, Peter Choong Yi Wong MBBS, MRCPCH, Koh Cheng Thoon MBBS, MRCPCH, MMED (Paediatrics), Natalie Woon Hui Tan MBBS, MRCPCH   +6 more
doaj   +1 more source

A single dose of recombinant adenoviral vector rabies vaccine expressing two copies of glycoprotein protects mice from lethal virus challenge

Journal of Infection in Developing Countries
Introduction: Rabies is a fatal infectious disease, that poses a major public health threat in developing countries. With an annual death toll of approximately 59,000, more than half of which are children, an urgent need exists for a safe, affordable ...
Qunlong Li, Hongzhuan He, Yuxi Zhou, Jihong Wang, Huan Chen, Hui Liu   +5 more
doaj   +1 more source

Publication trends in research on oral rabies vaccination in animals: A bibliometric analysis

Open Veterinary Journal
Background: Rabies remains a serious global zoonotic disease, and oral rabies vaccine for animals is a critical strategy for its control and eradication.
Heru Susetya, Morsid Andityas, Dian Meididewi Nuraini   +2 more
doaj   +1 more source

The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study

Travel Medicine and Infectious Disease
Background: The combination of passive immune agents (human rabies immune globulin (HRIG) and equine rabies antiserum (ERA)) with vaccines are effective measures for preventing the onset of rabies post exposure. However, ERA and HRIG have potential risks
Yin Yin, Min Jia, Yufeng Li, Wei Zhao, Shuhong Chen, Peiyuan Huo, Qinghua Zhao, Lan Yu, Cha Wang, Yirui Ma, Meixia Wang, Jing Zhang   +11 more
doaj   +1 more source

Immune response after rabies oral immunization in mice

Brazilian Archives of Biology and Technology, 2013
The objective of this study was to formulate an anti-rabies oral vaccine from the cell culture vaccine PV TECPAR to elicit the production of antibodies against the rabies in mice.
Camila Sloboda Pacheco da Silva, Ernesto Renato Krüger, Jorge Victor Bacila Agottani, Rubens Chaguri de Oliveira, Sandro Pereira, Tânia Regina Penha, Rüdiger Daniel Ollhoff   +6 more
doaj  

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine - China, 2021-2024. [PDF]

China CDC Wkly
Zhang L, Li K, Li Y, Fan C, Li Y, Ren M, Cao L, Yu W, Yin Z.   +8 more
europepmc   +1 more source

Does India's Zero by 30 Strategic Plan Need the Addition of the Rabies Vaccine to the Universal Immunisation Programme? [PDF]

Health Serv Insights, 2023
Mukhida S, Das NK, Palal D, Verma P, Johnson S.   +4 more
europepmc   +1 more source

Kinetics of rabies-neutralising antibodies in non-human primates after the injection of adjuvanted and inactivated rabies vaccine. [PDF]

Onderstepoort J Vet Res
Souissi Y, Handous M, Bayoudh M, Torjemane S, Khamassi Khbou M.   +4 more
europepmc   +1 more source

An engineered VSV-vectored rabies vaccine with an RABV-G-L71S mutation. [PDF]

iScience
Yue M, Zhu Y, Wu H, Yan S, Zhang J, Chang M, Liu L, Huang H, Lu J, Wu W, Chen R, Wu S, Gao Y, Cao Y, Ding H, Zheng Q, Wang Y, Yuan Q, Xiong H, Tian K, Zhang T, Xia N.   +21 more
europepmc   +1 more source